Platelet Activation Markers and Soluble Adhesion Molecules in Patients with Systemic Lupus Erythematosus

References

• Hunningshake G. W., Fauci A. S. Pulmonary involvement in the collagen vascular diseases. Am. Rev. Respir. Di.s. 1979; 119: 471–503
   PubMedGoogle Scholar
• Spiera H., Rothenberg R. R. Myocardial infarction in four young patients with systemic lupus erythematosus. J. Rheumatol. 1983; 10: 464–466
   PubMedGoogle Scholar
• Urowitz M B., Bookman A. A.M., Koehler B. E., Gordon D. A., Smythe H. A., Ogryzlo M A. The bimodal mortality pattern of systemic lupus erythematosus. Am. J. Med. 1976; 60: 221–225
   PubMed Web of Science ®Google Scholar
• Ross R. The pathogenesis of atherosclerosis. Nature 1993; 37: 801–809
   Google Scholar
• Libby P., Stephen J., Warner C. Interleukin 1: a mitogen for human vascular smooth muscle cells that induces the release of growth-inhibitory prostanoids. J. Clin. Invest. 1988; 81: 487–498
   PubMed Web of Science ®Google Scholar
• Hansson G. K., Holm J., Jonnson L. Detection of activated T-lymphocytes in the human atherosclerotic plaque. Am. J. Pathol. 1989; 135: 169–175
   PubMed Web of Science ®Google Scholar
• Spinger T. A. Adhesion receptors of the immune system. Nature 1990; 346: 425–434
   PubMedGoogle Scholar
• Bevilacqua M. P. Endolhelial-leukocyte adhesion molecules. Ann. Rev. Immunol. 1993; 11: 767–804
   PubMed Web of Science ®Google Scholar
• Fries J. W.U., Williams A. J., Atkins R. C., Newman W., Lipscomb M. F., Collins T. Expression of VCAM-I and E-selectin in an in vivo model of endothelial activation. Am. J. Pathol. 1993; 143: 725–737
   PubMed Web of Science ®Google Scholar
• Davies M. J, Gordon J. L., Gearing A. J.H., Pigott R., Woolf N., Katz D., et al. The expression]of the adhesion molecules 1CAM-1, VCAM-1, PECAM-I, and E-selectin in human atheroscrelosis. J. Pathol. 1993; 171: 223–229
   PubMed Web of Science ®Google Scholar
• Tsuchiya N., Shiota M. A. Yamaguchi and K. Ito. Elevated serum level of soluble HLA class I antigen in patients with systemic lupus erythematosus. Arthritis Rheum. 1996; 39: 792–796
   PubMed Web of Science ®Google Scholar
• Wolf R. E., Brolsford W. G. Soluble imerleukin-2 receptors in systemic lupus erythematosus. Arthritis Rheum. 1988; 31: 729–735
   PubMed Web of Science ®Google Scholar
• Takano S., Kimura A., Ohdama S., Aoki N. Plasma thrombomodulin in health and diseases. Blood 1990; 76: 2024–2029
   PubMed Web of Science ®Google Scholar
• Testa S., Manna A., Porcellini A., Maffi F., Morstabilini G., Denti N., et al. Increased plasma level of vascular endothelial glycoprotein thrombomodulin as an early indicator of endothelial damage in bone marrow transplantation. Bone Marrow Transplant 1996; 18: 383–388
   PubMed Web of Science ®Google Scholar
• Nomura S., Shouzu A., Omoto S., Hayakawa T., Kagawa H., Nishikawa M., et al. Effect of cilostazol on soluble adhesion molecules and platelet-derived microparticles in patients with diabetes. Thwmb. Huemost. 1998; 80: 388–392
   PubMed Web of Science ®Google Scholar
• Omoto S., Nomura S., Shouzu A., Hayakawa T., Shimizu H., Miyake Y., et al. Significance of platelet-derived micro-particles and activated platelets in diabetic nephropathy. Nephron 1999; 81: 271–277
   PubMed Web of Science ®Google Scholar
• Abrams C. H.S., Ellison N., Budzynski A. Z., Shattil S. J. Direct detection of activated platelets and platelet-derived microparticles in humans. Blood 1990; 75: 128–138
   PubMed Web of Science ®Google Scholar
• Murakami T., Komiyama Y., Masuda M., Kido H., Nomura S., Fukuhara S., et al. Flow cytometric analysis of platelet activation markers CD62P and CD63 in patients with coronary artery disease. Eur. J. Clin. Invest. 1996; 26: 996–1003
   PubMed Web of Science ®Google Scholar
• Sims P. J., Faioni E. M., Wiedmer T., Shattil S. J. Complement proteins C5b-9 cause release of membrane vesicles from the platelet surface that are enriched in the membrane receptor for coagulation factor Va and express prothrombinase activity. J. Biol. Chem. 1988; 263: 18205–18212
   PubMed Web of Science ®Google Scholar
• Nomura S., Komiyama Y., Miyake T., Miyazaki Y., Kido H., Suzuki M., et al. Amyloid β-protein precursor-rich platelet microparticles in thrombotic disease. Thromb. Haemo.it. 1994; 72: 519–522
   PubMed Web of Science ®Google Scholar
• Nomura S., Suzuki M., Katsura K., Xie G. L., Miyalaki Y., Miyake T., et al. Platelet-derived microparticles may influence the development of atherosclerosis in diabetes mellitus. Atherosclerosis 1995; 116: 235–240
   PubMed Web of Science ®Google Scholar
• Hochberg M. C. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997; 40: 1725
   PubMed Web of Science ®Google Scholar
• Smith E. L., Shmerling R. H. The American College of Rheumatology criteria for the classification of systemic lupus erythematosus: strengths, weaknesses, and opportunities for improvement. Lupus 1999; 8: 586–595
   PubMedGoogle Scholar
• Nomura S., Suzuki M., Kido H., Yamaguchi K., Fukuroi T., Yanabu M., et al. Differences between platelet and micropartiele glycoprotein llb/IIIa. Cytometry 1992; 13: 621–629
   PubMedGoogle Scholar
• Miyake T., Nomura S., Komiyama Y., Miyazaki Y., Kagawa H., Masuda M., et al. Effect of a new monoclonal anti-glycoprotein IX antibody, KMP-9, on high shear-induced platelet aggregation. Thromb. Haemosi. 1997; 78: 902–909
   PubMed Web of Science ®Google Scholar
• Yanabu M., Ozaki Y., Nomura S., Miyake T., Miyazaki Y., Kagawa H., et al. Tyrosine phosphorylation and p72syk activation by an anti-glycoprotein lb monoclonal antibody. Blood 1997; 89: 1590–1598
   PubMed Web of Science ®Google Scholar
• Moake J. L. von Willebrand factor and the pathophysiology of thrombotic thrombocytopenia: from human studies to a new animal model (editorial). Lab. Invest. 1988; 59: 415–417
   PubMedGoogle Scholar
• Packham M. A., Mustard J. F. The role of platelets in the development and complications of atherosclerosis. Semin. Hematol. 1986; 23: 8–19
   PubMed Web of Science ®Google Scholar
• Tschope D., Spangenberg P., Esser J., Schwippert B., Kehrel B., Rosen P., et al. Flow cytometric detection of surface membrane alterations and concomitant changes in the cytoskeletal actins status of activated platelets. Cytometry 1990; 11: 652–656
   PubMedGoogle Scholar
• Matzdorff A. C., Kuhnel G., Kemkes-Matthes B., Pralle H., Voss R., Fareed J. Effect of glycoprotein Ilbllla inhibitors on CD62p expression, platelet aggregates, and microparticles in vitro. J. Lab. Clin. Med. 2000; 135: 247–245
   PubMedGoogle Scholar
• Leytin V., Mody M., Semple J. W., Garvey B., Freed-Man J. Flow cytometric parameters for characterizing platelet activation by measuring P-selectin (CD62P) expression: theoretical consieration and evaluation in thrombin-treated platelet populations. Biochem. Biohv.s. Res. Commim. 2000; 269: 85–90
   PubMedGoogle Scholar
• Mosmann T. R., Cherwinski H., Bond M. W., Giedlin M. A., Coffman R. L. Two types of mouse helper T cells. I. definition of according to profiles of lymphokine activities and secrete proteins. J. Immunol. 1986; 136: 2348–2357
   PubMed Web of Science ®Google Scholar
• Piali L., Hammel P., Uherek C., Bachmann F., Gisler R. H., Dunon D., et al. CD31/PECAM-1 is a Hgand for αv β3 integrin involved in adhesion of leukocytes to endothelium. J. Cell. Biol. 1995; 130: 451–460
   PubMed Web of Science ®Google Scholar
• Venturini C M., Kaplan J. E. Thrombin induces platelet adhesion to endothelial cells. Semin. Thromb. Hemost. 1992; 18: 275–283
   PubMedGoogle Scholar
• Wagner D. D. The Weibel-Palade body: The storage granule for von Willebrand factor and P-selectin. 1993; 70: 105–110
   Google Scholar
• Miyazaki Y., Nomura S., Miyake T., Kagawa H., Kitada C., Taniguchi H., et al. High shear stress can initiate both platelet aggregation and shedding of procoagulant containing microparticles. Blood 1996; 88: 3456–3464
   PubMed Web of Science ®Google Scholar
• Barry O. P., Pratico D., Savani R. C, Fitzgerald G. A. Modulation of monocyte-endothelial cell interactions by platelet microparticles. J. Clin. Invest. 1998; 102: 136–144
   PubMed Web of Science ®Google Scholar
• Kiraz S., Ertenli I., Benekli M., Haznedaroglu I. C., Calguneri M., Celik I. Clinical significance of hemostatic markers and thrombomodulin in systemic lupus erythematosus: evidence for a prothrombotic state. Lupus 1999; 8: 737–741
   PubMed Web of Science ®Google Scholar
• Boehme M. W., Raeth U., Galle P R., Stremmel W., Scherbaum W. A. Serum thrombomodulin - a reliable marker of disease activity in systemic lupus erythematosus (SLE): advantage over established serological parameters to indicate disease activity. Clin. Exp. Immunol. 2000; 119: 189–195
   PubMed Web of Science ®Google Scholar
• Boehme M. W.J., Schmitt W. H., Youinou P., Stremmel W. R., Gross W. L. Clinical relevance of elevated serum thrombomodulin and soluble E-selectin in patients with Wegener's granulomatosis and other systemic vasculitides. Am. J. Hematol. 1996; 101: 387–394
   Google Scholar